利卡西平
臨床資料 | |
---|---|
ATC碼 |
|
藥物動力學數據 | |
血漿蛋白結合率 | <40% |
代謝產物 | Glucuronides |
排泄途徑 | Mainly renal |
識別資訊 | |
| |
CAS號 | 29331-92-8 |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.122.427 |
化學資訊 | |
化學式 | C15H14N2O2 |
摩爾質量 | 254.29 g·mol−1 |
3D模型(JSmol) | |
手性 | Racemic mixture |
| |
|
利卡西平(英語:Licarbazepine)是一種含氮有機化合物,分子式C15H14N2O2,可作為電壓門控鈉離子通道的阻滯劑,能作為情緒穩定劑[1],也是奧卡西平在體內的活性代謝產物[2]。
參考文獻
- ^ Singh RP, Asconapé JJ. A review of eslicarbazepine acetate for the adjunctive treatment of partial-onset epilepsy. Journal of Central Nervous System Disease. 2011, 3: 179–87. PMC 3663619 . PMID 23861647. doi:10.4137/JCNSD.S4888.
- ^ Bialer M, Soares-da-Silva P. Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia. June 2012, 53 (6): 935–46. PMID 22612290. S2CID 21233948. doi:10.1111/j.1528-1167.2012.03519.x .